title: Should patients with "borderline" lesions of Banff criteria be treated by renal transplantation?
authors.affiliation: Nephrology Department, Lyon Sud Hospital, Pierre-Benite, France.
authors.forename: C
authors.initials: C
authors.lastname: Lorriaux
authors.forename: B
authors.initials: B
authors.lastname: Mac Gregor
authors.forename: F
authors.initials: F
authors.lastname: Dijoud
authors.forename: R
authors.initials: R
authors.lastname: Cahen
authors.forename: J L
authors.initials: JL
authors.lastname: Touraine
authors.forename: C
authors.initials: C
authors.lastname: Pouteil-Nobel
mesh_terms: D001706:Biopsy; D006084:Graft Rejection / Q000145:classification* / Q000473:pathology* / Q000628:therapy; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000473:pathology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D012086:Reoperation; D012189:Retrospective Studies
chemical_list: D008775:Methylprednisolone